key: cord-0706252-9btox1c7
authors: Bedel, Cihan; Korkut, Mustafa
title: Neutrophil-to-Lymphocyte Ratio and Covid-19
date: 2020-12-21
journal: Shock
DOI: 10.1097/shk.0000000000001712
sha: 58258bb998fa84601789c2ce2473bb992bdd3d85
doc_id: 706252
cord_uid: 9btox1c7

nan

To the Editor: We read with great interest the article recently published by Tatum et al. (1) entitled ''Neutrophil-to-lymphocyte ratio and outcomes in Louisiana COVID-19 patients.'' They found that neutrophil-to-lymphocyte ratio (NLR) is a prognostic factor for endotracheal intubation on hospitalization and an independent predictor of mortality risk in SARS-CoV-2 patients. We thank the authors for their valuable contribution to the literature in these difficult conditions. However, we think there are some points that need to be discussed.

The drug use of the patients has not been mentioned in this article and it would be appropriate to mention the use of drugs such as glucocorticoids that may affect the NLR value. As it is known, while the neutrophil count increases with the use of glucocorticoids, other circulating cells such as eosinophils, monocytes, and lymphocytes are reduced (2) . This is an indication that it affects NLR values, and it would be more appropriate for the authors to report how many patients were taking corticosteroids.

NLR, one of the routine blood parameters, has been extensively studied in many diseases and remains important (3). Studies have reported that NLR is significantly higher in applications related to infection. Similarly, stress factors such as trauma and gastrointestinal system bleeding may cause increases in NLR (4, 5) . Therefore, providing useful information about infection, malignancy, alcohol use, smoking, gastrointestinal bleeding, renal/metabolic conditions, encephalopathy, surgical procedures, and additional medical procedures that may affect NLR values will provide useful information. As a result, NLR can be affected by many factors. The prognostic routine clinical use of these parameters in COVID-19 patients is not yet reasonable. Prospective and multicenter studies are needed. The authors report no conflicts of interest.

Pathogenetic insights from the treatment of rheumatoid arthritis

Cytokine therapeutics for the treatment of sepsis: why has nothing worked?

Cytokine drizzle-The rationale for abandoning

Neutrophil-tolymphocyte ratio and outcomes in Louisiana COVID-19 patients

Estimations of a degree of steroid induced leukocytosis in patients with acute infections

Association of platelet to lymphocyte and neutrophil to lymphocyte ratios with in-hospital mortality in patients with type A acute aortic dissection

Neutrophil-lymphocyte ratio predicts the outcome of intracerebral hemorrhage: a meta-analysis

A comparison between the ability of revised trauma score and Kampala trauma score in predicting mortality; a meta-analysis